The Middle East and Africa graft-versus-host disease (GVHD) treatment market was valued at USD 337.90 million in 2024 and is expected to reach USD 412.63 millio...
The Europe graft-versus-host disease (GVHD) treatment market was valued at USD 583.49 Million in 2024 and is expected to reach USD 823.47 million by 2032. Durin...
The Asia-Pacific graft-versus-host disease (GVHD) treatment market was valued at USD 478.64 million 2024 and is expected to reach USD 638.70 million by 2032. Du...